Form 4: Recursion Pharmaceuticals COO Tina Marriott Executes Stock Option and Sells Shares Under 10b5-1 Plan

Tina Marriott, President and COO of Recursion Pharmaceuticals, exercised stock options and sold 6,000 shares of Class A Common Stock on August 29, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On August 29, 2024, Tina Marriott, the President and COO of Recursion Pharmaceuticals, exercised stock options to acquire 6,000 shares of Class A Common Stock at a price of $1.06 per share.
• Simultaneously, Marriott sold 6,000 shares of Class A Common Stock at a weighted average price of $7.5627, with individual sales ranging from $7.34 to $7.77.
• These transactions were executed under a pre-arranged 10b5-1 trading plan established on March 1, 2024.
• Following these transactions, Marriott directly owns 521,138 shares of Class A Common Stock.
• Marriott also holds various stock options to purchase additional shares at prices ranging from $2.48 to $11.40, with expiration dates extending to February 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by an executive under a pre-arranged plan. There's no indication of positive or negative implications for the company's performance.

Positives

• The transactions were conducted under a pre-arranged 10b5-1 trading plan, which can mitigate concerns about insider trading.

Risks

• Executive stock sales can sometimes be perceived negatively by investors, although the 10b5-1 plan mitigates this concern.

Future Outlook

The document does not contain specific forward-looking statements, but it indicates ongoing vesting of stock options.

Industry Context

Executive stock transactions are common in publicly traded companies, and the use of 10b5-1 plans is a standard practice to avoid insider trading concerns. This filing provides transparency into the trading activities of a key executive at Recursion Pharmaceuticals.

Comparison to Industry Standards

• Executive compensation packages often include stock options to align management's interests with those of shareholders.
• The vesting schedules and exercise prices of the options are typical for the industry.
• The use of a 10b5-1 trading plan is a common practice among executives to manage their stock holdings in a compliant manner.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the 10b5-1 plan mitigates concerns about insider information.

Key Dates